Procardia and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take Procardia (nifedipine), especially for people who are female, 60+ old, also take Dilantin, and have Convulsion.

The phase IV clinical study analyzes which people have Erythema multiforme when taking Procardia. It is created by eHealthMe based on reports of 14,828 people who have side effects when taking Procardia from the FDA, and is updated regularly.

What is Procardia?

Procardia has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 15,151 Procardia users. Check the latest studies of Procardia.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,705 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

On Jul, 20, 2026

14,828 people reported to have side effects when taking Procardia.
Among them, 35 people (0.24%) have Erythema multiforme.

Could Procardia cause Erythema multiforme?

Among these 35 people:

What is the gender of people who have Erythema multiforme when taking Procardia? *

female: 61.76 %
male: 38.24 %

What is the age of people who have Erythema multiforme when taking Procardia? *

What are other drugs people take besides Procardia? *

What are other side effects people have besides Erythema multiforme? *

Dehydration (dryness resulting from the removal of water): 4 people, 11.43%
Rashes (redness): 4 people, 11.43%
Blood Glucose Increased: 3 people, 8.57%
Septic Shock (shock due to blood infection): 3 people, 8.57%
Oral Disorder (mouth disease): 3 people, 8.57%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 5.71%
Hyperglycemia (high blood sugar): 2 people, 5.71%
Dyspnea (difficult or laboured breathing): 2 people, 5.71%
Depression: 2 people, 5.71%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 5.71%

What are the existing conditions these people have? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 9 people, 25.71%
Subarachnoid Haemorrhage (blood leaks into the space between two membranes that surround the brain): 3 people, 8.57%
Renal Cell Carcinoma (a kidney cancer): 3 people, 8.57%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 5.71%
Pain: 2 people, 5.71%
Mydriasis (a dilation of the pupil): 2 people, 5.71%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.71%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.71%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 2.86%
Lymphangitis (inflammation of the lymph channel): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procardia:

Procardia (15,151 reports)

Browse all side effects of Procardia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythema multiforme:

Erythema multiforme (1,705 drugs)

Browse all the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,920 conditions)

Related publications that referenced our studies

Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia) and Procardia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.